semaglutide med – SpringCare Clinic Affordable Semaglutide for weight loss

A Breakthrough Award, New Evidence in Parkinson's and Heart Disease

COA-backed 99% purity for metabolic, incretin and receptor-signalling research

I'm sharing my personal journey accessing compounded GLP-1 medications like Tirzepatide through Mochi Health

This graph diagrams utilization, unit cost, and cost as a percent of overall medical cost trend: note that by the middle of 2023, GLP-1 drug costs for Group health plan members comprised 13.6% of a major pharmacy benefit management (PBM) company, shown in the third bar

This narrative review synthesizes data from randomized controlled trials (RCTs) and real-world evidence (RWE) on Wegovy (semaglutide 2.4 mg, a recombinant DNA-derived GLP-1RA) in obesity with CVD, with a focus on SELECT, mediation analyses suggesting weight-independent CV effects, and outcomes in obesity-related HFpEF

A large observational study confirms previous clinical data on semaglutide lowering the risk of heart attack, stroke, death and separate hospitalization for heart failure.